{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T17:00:53Z","timestamp":1788454853346,"version":"build-2803163510"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004330","name":"GSK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ebiom.2026.106296","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T12:27:00Z","timestamp":1779452820000},"page":"106296","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Estimated efficacy of the adjuvanted RSVPreF3 vaccine against diverse and worldwide predominant RSV strains, irrespective of RSV F protein variation: results of a post-hoc analysis from the AReSVi-006 trial"],"prefix":"10.1016","volume":"128","author":[{"given":"Jonathan","family":"De Smedt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Gruselle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lionel","family":"Sacconnay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine","family":"Baup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stebin","family":"Xavier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Crudele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lie","family":"Olivier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yannick","family":"Vanloubbeeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Van der Wielen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Pierre","family":"David","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Dezutter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucile","family":"Warter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebiom.2026.106296_bib1","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1016\/S0140-6736(22)00478-0","article-title":"Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis","volume":"399","author":"Li","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.ebiom.2026.106296_bib2","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1093\/infdis\/jiab040","article-title":"Disease burden estimates of respiratory syncytial virus related acute respiratory infections in adults with comorbidity: a systematic review and meta-analysis","volume":"226","author":"Shi","year":"2022","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ebiom.2026.106296_bib3","doi-asserted-by":"crossref","DOI":"10.1111\/irv.13031","article-title":"Respiratory syncytial virus disease burden in adults aged 60 years and older in high-income countries: a systematic literature review and meta-analysis","volume":"17","author":"Savic","year":"2023","journal-title":"Influenza Other Respir Viruses"},{"key":"10.1016\/j.ebiom.2026.106296_bib4","doi-asserted-by":"crossref","first-page":"S577","DOI":"10.1093\/infdis\/jiz059","article-title":"Global disease burden estimates of respiratory syncytial virus-associated acute respiratory infection in older adults in 2015: a systematic review and meta-analysis","volume":"222","author":"Shi","year":"2020","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ebiom.2026.106296_bib5","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1093\/infdis\/jiad510","article-title":"Respiratory syncytial virus-associated hospitalization in adults with comorbidities in 2 European countries: a modeling study","volume":"229","author":"Osei-Yeboah","year":"2024","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ebiom.2026.106296_bib6","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jaci.2025.10.023","article-title":"A promise fulfilled: updates on respiratory syncytial virus vaccines and monoclonal antibodies","volume":"157","author":"Murray","year":"2026","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.ebiom.2026.106296_bib7","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1093\/cid\/ciae010","article-title":"Efficacy and safety of respiratory syncytial virus (RSV) prefusion F protein vaccine (RSVPreF3 OA) in older adults over 2 RSV seasons","volume":"78","author":"Ison","year":"2024","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ebiom.2026.106296_bib8","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1056\/NEJMoa2209604","article-title":"Respiratory syncytial virus prefusion F protein vaccine in older adults","volume":"388","author":"Papi","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ebiom.2026.106296_bib9","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1056\/NEJMoa2213836","article-title":"Efficacy and safety of a bivalent RSV prefusion F vaccine in older adults","volume":"388","author":"Walsh","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ebiom.2026.106296_bib10","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1056\/NEJMoa2307079","article-title":"Efficacy and safety of an mRNA-Based RSV PreF vaccine in older adults","volume":"389","author":"Wilson","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ebiom.2026.106296_bib11","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S2213-2600(25)00048-7","volume":"13","author":"Ison","year":"2025","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.ebiom.2026.106296_bib12","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1056\/NEJMp2216358","article-title":"The journey to RSV vaccines - heralding an era of structure-based design","volume":"388","author":"Graham","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ebiom.2026.106296_bib13","doi-asserted-by":"crossref","DOI":"10.1099\/jgv.0.002095","article-title":"Recent advances in the prevention and treatment of respiratory syncytial virus disease","volume":"106","author":"Sanchez-Martinez","year":"2025","journal-title":"J Gen Virol"},{"key":"10.1016\/j.ebiom.2026.106296_bib14","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.tim.2017.09.009","article-title":"Clinical potential of prefusion RSV F-specific antibodies","volume":"26","author":"Rossey","year":"2018","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.ebiom.2026.106296_bib15","doi-asserted-by":"crossref","DOI":"10.1002\/rmv.1968","article-title":"Molecular epidemiology of respiratory syncytial virus","volume":"28","author":"Pangesti","year":"2018","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.ebiom.2026.106296_bib16","first-page":"3","article-title":"Respiratory syncytial virus: virology, reverse genetics, and pathogenesis of disease","volume":"372","author":"Collins","year":"2013","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.ebiom.2026.106296_bib17","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1038\/s41467-024-47118-6","article-title":"The genomic evolutionary dynamics and global circulation patterns of respiratory syncytial virus","volume":"15","author":"Langedijk","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.ebiom.2026.106296_bib18","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.02083-21","article-title":"Molecular evolution of attachment glycoprotein (G) and fusion protein (F) genes of respiratory syncytial virus ON1 and BA9 strains in Xiamen, China","volume":"10","author":"Sun","year":"2022","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.ebiom.2026.106296_bib19","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01828-20","article-title":"Global molecular epidemiology of respiratory syncytial virus from the 2017-2018 INFORM-RSV study","volume":"59","author":"Tabor","year":"2020","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ebiom.2026.106296_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcv.2022.105223","article-title":"A multi-center study to determine genetic variations in the fusion gene of respiratory syncytial virus (RSV) from children <2 years of age in the U.S","volume":"154","author":"Adhikari","year":"2022","journal-title":"J Clin Virol"},{"key":"10.1016\/j.ebiom.2026.106296_bib21","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.virs.2024.09.002","article-title":"A multi-center study on genetic variations in the fusion protein of respiratory syncytial virus from children with acute lower respiratory tract infections in China during 2017-2021","volume":"39","author":"Fu","year":"2024","journal-title":"Virol Sin"},{"key":"10.1016\/j.ebiom.2026.106296_bib22","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.3390\/idr16050081","article-title":"The cumulative variations of respiratory syncytial virus fusion protein (F) in ten consecutive years in China","volume":"16","author":"Wang","year":"2024","journal-title":"Infect Dis Rep"},{"key":"10.1016\/j.ebiom.2026.106296_bib23","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3390\/pathogens8020067","article-title":"A contemporary view of respiratory syncytial virus (RSV) biology and strain-specific differences","volume":"8","author":"Pandya","year":"2019","journal-title":"Pathogens"},{"key":"10.1016\/j.ebiom.2026.106296_bib24","doi-asserted-by":"crossref","first-page":"3898","DOI":"10.1038\/s41598-019-40387-y","article-title":"Emergence of new antigenic epitopes in the glycoproteins of human respiratory syncytial virus collected from a US surveillance study, 2015-17","volume":"9","author":"Bin","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.ebiom.2026.106296_bib25","doi-asserted-by":"crossref","first-page":"4491","DOI":"10.1038\/s41598-018-22826-4","article-title":"Genetic variations in the fusion protein of respiratory syncytial virus isolated from children hospitalized with community-acquired pneumonia in China","volume":"8","author":"Chen","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.ebiom.2026.106296_bib26","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/irv.12727","article-title":"Characterization of human respiratory syncytial virus (RSV) isolated from HIV-exposed-uninfected and HIV-unexposed infants in South Africa during 2015-2017","volume":"14","author":"Liu","year":"2020","journal-title":"Influenza Other Respir Viruses"},{"key":"10.1016\/j.ebiom.2026.106296_bib27","doi-asserted-by":"crossref","first-page":"6660","DOI":"10.1016\/j.vaccine.2018.09.056","article-title":"Antigenic and sequence variability of the human respiratory syncytial virus F glycoprotein compared to related viruses in a comprehensive dataset","volume":"36","author":"Mas","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.ebiom.2026.106296_bib28","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1093\/infdis\/jiae636","article-title":"Amino acid substitutions in the fusion protein of respiratory syncytial virus in Fukushima, Japan, during 2008-2023 and their effects","volume":"231","author":"Okabe","year":"2025","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ebiom.2026.106296_bib29","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adg6050","article-title":"The RSVPreF3-AS01 vaccine elicits broad neutralization of contemporary and antigenically distant respiratory syncytial virus strains","volume":"15","author":"Sacconnay","year":"2023","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.ebiom.2026.106296_bib30","doi-asserted-by":"crossref","DOI":"10.1128\/msphere.00860-24","article-title":"Functional implications of respiratory syncytial virus F sequence variability: a comparative analysis using contemporary RSV isolates","volume":"10","author":"Stobbelaar","year":"2025","journal-title":"mSphere"},{"key":"10.1016\/j.ebiom.2026.106296_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcv.2024.105759","article-title":"The molecular epidemiology of respiratory syncytial virus in Ontario, Canada from 2022-2024 using a custom whole genome sequencing assay and analytics package","volume":"176","author":"Wong","year":"2025","journal-title":"J Clin Virol"},{"key":"10.1016\/j.ebiom.2026.106296_bib32","article-title":"Sequence variability of the respiratory syncytial virus (RSV) fusion gene among contemporary and historical genotypes of RSV\/A and RSV\/B","volume":"12","author":"Hause","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ebiom.2026.106296_bib33","doi-asserted-by":"crossref","first-page":"e4400","DOI":"10.1093\/cid\/ciaa951","article-title":"Suptavumab for the prevention of medically attended respiratory syncytial virus infection in preterm infants","volume":"73","author":"Sim\u00f5es","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ebiom.2026.106296_bib34","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1093\/infdis\/jiy189","article-title":"Prevalence and significance of substitutions in the fusion protein of respiratory syncytial virus resulting in neutralization escape from antibody MEDI8897","volume":"218","author":"Zhu","year":"2018","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ebiom.2026.106296_bib35","doi-asserted-by":"crossref","first-page":"D20","DOI":"10.1093\/nar\/gkae979","article-title":"Database resources of the National Center for Biotechnology Information in 2025","volume":"53","author":"Sayers","year":"2025","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.ebiom.2026.106296_bib36","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/gch2.1018","article-title":"Data, disease and diplomacy: GISAID\u2019s innovative contribution to global health","volume":"1","author":"Elbe","year":"2017","journal-title":"Glob Chall"},{"key":"10.1016\/j.ebiom.2026.106296_bib37","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.drudis.2022.01.007","article-title":"Communicating regulatory high-throughput sequencing data using BioCompute objects","volume":"27","author":"King","year":"2022","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.ebiom.2026.106296_bib38","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1080\/03610929808832160","article-title":"Exact power and sample size for vaccine efficacy studies","volume":"27","author":"Chan","year":"1998","journal-title":"Commun Stat Theory Methods"},{"key":"10.1016\/j.ebiom.2026.106296_bib39","first-page":"383","article-title":"FDA approves new RSV monoclonal antibody to protect infants","volume":"334","author":"Anderer","year":"2025","journal-title":"JAMA"},{"key":"10.1016\/j.ebiom.2026.106296_bib40","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1007\/s40121-024-01012-2","article-title":"Differences between RSV A and RSV B subgroups and implications for pharmaceutical preventive measures","volume":"13","author":"Nuttens","year":"2024","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.ebiom.2026.106296_bib41","series-title":"Statement on the antigen composition of COVID-19 vaccines","year":"2024"},{"key":"10.1016\/j.ebiom.2026.106296_bib42","series-title":"Recommendations for influenza vaccine composition","year":"2025"},{"key":"10.1016\/j.ebiom.2026.106296_bib43","doi-asserted-by":"crossref","first-page":"4325","DOI":"10.1038\/s41467-023-39736-3","article-title":"Estimating long-term vaccine effectiveness against SARS-CoV-2 variants: a model-based approach","volume":"14","author":"Hogan","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.ebiom.2026.106296_bib44","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.02979-21","article-title":"The impact of evolving SARS-CoV-2 mutations and variants on COVID-19 vaccines","volume":"13","author":"McLean","year":"2022","journal-title":"mBio"},{"key":"10.1016\/j.ebiom.2026.106296_bib45","doi-asserted-by":"crossref","first-page":"932","DOI":"10.5694\/j.1326-5377.1961.tb70131.x","article-title":"A syncytial virus associated with epidemic disease of the lower respiratory tract in infants and young children","volume":"2","author":"Lewis","year":"1961","journal-title":"Med J Aust"},{"key":"10.1016\/j.ebiom.2026.106296_bib46","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1126\/science.1243283","article-title":"Structure-based design of a fusion glycoprotein vaccine for respiratory syncytial virus","volume":"342","author":"McLellan","year":"2013","journal-title":"Science"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396426001787?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396426001787?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T08:43:53Z","timestamp":1781081033000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396426001787"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":46,"alternative-id":["S2352396426001787"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2026.106296","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Estimated efficacy of the adjuvanted RSVPreF3 vaccine against diverse and worldwide predominant RSV strains, irrespective of RSV F protein variation: results of a post-hoc analysis from the AReSVi-006 trial","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2026.106296","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106296"}}